Subscribe to RSS
Download PDF
DOI: 10.1055/a-1839-5185
Identifying factors associated with detection of sessile gastric polyps in patients with familial adenomatous polyposis
Abstract
Background and study aims Gastric cancer (GC) is increasingly reported and a leading cause of death in patients with familial adenomatous polyposis (FAP). Identifying features in patients with FAP who harbor sessile gastric polyps, likely precursors to GC, may lead to alterations in endoscopic surveillance in those patients and allow endoscopic intervention to decrease the risk of GC. The aim of this study was to identify demographic and clinical factors in patients with FAP who harbor sessile gastric polyps.
Patients and methods We retrospectively compared demographic, clinical, and endoscopic features in consecutive adult patients with FAP who presented for a surveillance endoscopy at a tertiary-care center with a FAP registry who harbor sessile gastric polyps to those without them. Sessile gastric polyps included pyloric gland adenomas, gastric adenomas, hyperplastic polyps, and fundic gland polyps with high-grade dysplasia. We also display the location of germline APC pathogenic variants in patients with and without sessile gastric polyps.
Results Eighty patients with FAP were included. Their average age was 48 years and 70 % were male. Nineteen (24 %) had sessile gastric polyps. They were older (P < 0.03), more likely to have a family history of GC (P < 0.05), white mucosal patches in the proximal stomach (P < 0.001), and antral polyps (P < 0.026) compared to patients without a gastric neoplasm. No difference in Spigelman stage, extra-intestinal manifestations, or surgical history was note. 89 % of patients with a gastric neoplasm had an APC pathogenic variant 5’ to codon 1309.
Conclusions Specific demographic, endoscopic, and genotypic features are associated with patients with FAP who harbor sessile gastric polyps. We recommend heightened awareness of these factors when performing endoscopic surveillance of the stomach with resection of gastric neoplasia when identified.
Publication History
Received: 30 November 2021
Accepted after revision: 25 April 2022
Article published online:
15 August 2022
© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Mankaney G, Leone P, Cruise M. et al. Gastric cancer in FAP: a concerning rise in incidence. Familial Cancer 2017; 16: 371-376
- 2 Walton SJ, Frayling IM, Clark SK. Gastric tumours in FAP. Fam Cancer 2017; 16: 363-369
- 3 Bianchi LK, Burke CA, Bennett AE. et al. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol 2008; 6: 180-185
- 4 Offerhaus GJ, Giardiello FM, Krush AJ. et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastrointest Endosc 1992; 102: 1980-2
- 5 Burt RW. Gastric fundic gland polyps. Gastroenterology 2003; 125: 1462-9
- 6 Sample DC, Samadder NJ, Pappas LM. et al. Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients. BMC Gastroenterol 2018;
- 7 Cannon AR, Keener M, Neklason D. et al. Surgical interventions, malignancies, and causes of death in a FAP patient registry. J Gastrointest Surg 2021; 25: 452-456
- 8 Leone P, Mankaney G, Sarvapelli S. et al. Endoscopic and histologic features associated with gastric cancer in familial adenomatous polyposis. Gastrointest Endosc 2019; 89: 961-8
- 9 Kunnathu ND, Mankaney G, Bhatt A. et al. Worrisome endoscopic feature in the stomach of patients with familial adenomatous polyposis: the proximal white mucosal patch. Gastrointest Endosc 2018; 88: 569-570
- 10 Calavas L, Rivory J, Hervieu V. et al. Macroscopically visible flat dysplasia in the fundus of 3 patients with familial adenomatous polyposis. Gastrointest Endosc 2017; 85: 679-680
- 11 Wood LD, Salaria SN, Cruise MW. et al. Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms. Am J Surg Pathol 2014; 38: 389-93
- 12 Mankaney G, Cruise M, Sarvepalli S. et al. Surveillance for pathology associated with cancer on endoscopy (SPACE): criteria to identify high-risk gastric polyps in familial adenomatous polyposis. Gastrointest Endosc 2020; 92: 755-762
- 13 Shibata C, Ogawa H, Miura K. et al. Clinical characteristics of gastric cancer in patients with familial adenomatous polyposis. Tohoku J. Ex. Med 2013; 229: 143-6
- 14 Park SY, Ryu JK, Park JH. et al. Prevalence of gastric and duodenal polyps and risk factors for duodenal neoplasm in Korean patients with familial adenomatous polyposis. Gut Liver 2011; 5: 46-51
- 15 Jagelman DG, DeCosse JJ, Bussey HJ. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet 1988; 1: 1149-51
- 16 Guyton K, Alverdy JC. The gut microbiota and gastrointestinal surgery. Nat Rev Gastroenterol Hepatol 2017; 14: 43-54
- 17 Liang S, Mao Y, Liao M. et al. Gut microbiome associated with APC gene mutation in patients with intestinal adenomatous polyps. Int J Biol Sci 2020; 16: 135-146
- 18 Ngamruengphong S, Boardman LA, Heigh RI. et al. Gastric adenomas in familial adenomatous polyposis are common, but subtle, and have a benign course. Hered Cancer Clin Pract 2014; 12: 4